G. Blakey

Therapeutic Drug Monitoring and Population Pharmacokinetics of Digoxin in Jordanian Patients

S. Hamadi, N. Idkaidek, Ehab H. Shaker, 2013 .

Evaluation of a pharmacokinetic interaction between remacemide hydrochloride and phenobarbitone in healthy males.

M. Eadie, W. Hooper, J. Lockton, 2001, British journal of clinical pharmacology.

Quantitative Structure-Pharmacokinetics Relationships: I. Development of a Whole-Body Physiologically Based Model to Characterize Changes in Pharmacokinetics Across a Homologous Series of Barbiturates in the Rat

L. Aarons, I. Nestorov, M. Rowland, 1997, Journal of Pharmacokinetics and Biopharmaceutics.

Development of an assay for the extraction and quantification of nine 5-n-alkyl-5-ethyl barbituric acids in various rat tissues.

M. Rowland, D. Leahy, P. Ballard, 1999, Journal of Pharmaceutical and Biomedical Analysis.

Safety, tolerability, and pharmacokinetics of remacemide in children.

F. Besag, G. Blakey, R. Newton, 2001, Pediatric Neurology.

Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1.

J. Lockton, J. Plume, J. Perrett, 2003, British journal of clinical pharmacology.